Pharmabiz

TWN calls for generic lenacapavir to be made available to all at $40 a year

TWN calls for generic lenacapavir to be made available to all at $40 a year: Our Bureau, New Delhi Friday, September 26, 2025, 08:00 Hrs [IST] Third World Network (TWN), an indepe ...
Pharmabiz

Reduced GST on medical devices seen as catalyst for affordable healthcare & domestic manufacturing

Reduced GST on medical devices seen as catalyst for affordable healthcare & domestic manufacturing: Nandita Vijayasimha, Bengaluru Friday, September 26, 2025, 08:00 Hrs [IST] Indi ...
Pharmabiz

Pharmacovigilance programme for Ayush drugs marks growth in reporting of ADRs till June

Pharmacovigilance programme for Ayush drugs marks growth in reporting of ADRs till June: Gireesh Babu, New Delhi Friday, September 26, 2025, 08:00 Hrs [IST] The Pharmacovigilance ...
Pharmabiz

India & Mexico begin discussions to expand opportunities for Indian pharma industry

India & Mexico begin discussions to expand opportunities for Indian pharma industry: Shardul Nautiyal, Mumbai Friday, September 26, 2025, 08:00 Hrs [IST] In a significant step tow ...
Pharmabiz

Pharmacy academicians weigh in on NEP-based B.Pharm curriculum

Pharmacy academicians weigh in on NEP-based B.Pharm curriculum: Peethaambaran Kunnathoor, Chennai Friday, September 26, 2025, 08:00 Hrs [IST] Pharmacy education in India is set fo ...
Pharmabiz

Chugai Pharma files for additional indication of Avastin to treat neurofibromatosis type 2

Chugai Pharma files for additional indication of Avastin to treat neurofibromatosis type 2: Tokyo Thursday, September 25, 2025, 16:00 Hrs [IST] Chugai Pharmaceutical Co., Ltd. ann ...
Pharmabiz

Enhertu plus pertuzumab granted Priority Review in US as 1st-line treatment for patients with HER2-positive metastatic breast cancer

Enhertu plus pertuzumab granted Priority Review in US as 1st-line treatment for patients with HER2-positive metastatic breast cancer: Cambridge, UK Thursday, September 25, 2025, 0 ...
Pharmabiz

Alvogen Pharma announces sale to Lotus Pharmaceutical, creating a leading global specialized generics platform

Alvogen Pharma announces sale to Lotus Pharmaceutical, creating a leading global specialized generics platform: Morristown, New Jersey Thursday, September 25, 2025, 18:00 Hrs [IST ...
Pharmabiz

Sanofi commits an additional $625 million to Sanofi Ventures to accelerate investment in biotech and digital health innovation

Sanofi commits an additional $625 million to Sanofi Ventures to accelerate investment in biotech and digital health innovation: Paris Thursday, September 25, 2025, 14:00 Hrs [IST] ...
Pharmabiz

HCA Healthcare sets up its Global Capability Centre in India, opts Hyderabad as the strategic hub

Our Bureau, Bengaluru Thursday, September 25, 2025, 12:30 Hrs [IST] ...
Pharmabiz

Nethradhama with London Vision Clinic to strengthen ophthalmic education in India to conduct Forefront Refractive Surgery Course

Nethradhama with London Vision Clinic to strengthen ophthalmic education in India to conduct Forefront Refractive Surgery Course: Our Bureau, Bengaluru Thursday, September 25, 202 ...
Pharmabiz

Study says seven of ten pharma digital projects fail to deliver despite heavy spending

Study says seven of ten pharma digital projects fail to deliver despite heavy spending: Our Bureau, Mumbai Thursday, September 25, 2025, 17:30 Hrs [IST] Seven out of ten digital p ...